middle.news
Algorae Pharmaceuticals Advances AI-Driven Drug Pipeline with Strong Preclinical Wins
7:03pm on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Algorae Pharmaceuticals Advances AI-Driven Drug Pipeline with Strong Preclinical Wins
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Al-168 shows 94% restoration of endothelial cell proliferation in preclinical studies
AlgoraeOS generates 24 new oncology drug targets and begins Version 2.0 development
Al-116 outperforms standard dementia treatment in neuroprotection studies
Dr. Sarah Siggins appointed to Scientific Advisory Board to strengthen leadership
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE